EU Green Light for Dostarlimab in Some Endometrial Cancers ...Middle East

Medscape - News
A new PD-1 antagonist, dostarlimab, has been recommended for approval for use in some women with advanced/recurrent endometrial cancer. International Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( EU Green Light for Dostarlimab in Some Endometrial Cancers )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News